Can leuprolide therapy be optimized through pharmacogenetic approaches, and what genetic markers are associated with improved patient outcomes?
Gaurav ChauhanContributor
Can leuprolide therapy be optimized using pharmacogenetic approaches?
Share
Leuprolide therapy can potentially be optimized through pharmacogenetic approaches. Genetic markers like the GnRH receptor polymorphisms may impact treatment efficacy and patient outcomes.